登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Glycoprotein E (VZV)】

Glycoprotein E (VZV)信息

英文名称:Envelope (E) protein
中文名称:包膜(E)蛋白
靶点别称:gE-1,Envelope glycoprotein E,gE
上市药物数量:0
临床药物数量:1
最高研发阶段:临床一期

Glycoprotein E (VZV)分子别名

gE

Glycoprotein E (VZV)分子背景

Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster).

Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix®.

Glycoprotein E (VZV)临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定